Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Donald Bodenner

Concepts (247)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
14
2017
113
1.880
 Why?
Thyroidectomy
13
2019
61
1.720
 Why?
Parathyroidectomy
8
2018
46
1.220
 Why?
Thyroid Diseases
6
2019
27
1.170
 Why?
Parathyroid Neoplasms
5
2015
27
1.020
 Why?
Thyroid Gland
7
2017
76
0.970
 Why?
Parathyroid Hormone
8
2019
149
0.900
 Why?
Adenoma
4
2017
114
0.900
 Why?
Vitamin D Deficiency
5
2019
46
0.890
 Why?
Vitamin D
4
2015
91
0.770
 Why?
Fluorodeoxyglucose F18
6
2013
182
0.710
 Why?
Positron-Emission Tomography
7
2013
298
0.680
 Why?
Radiopharmaceuticals
7
2015
198
0.670
 Why?
Carcinoma, Papillary
4
2017
50
0.670
 Why?
Ambulatory Surgical Procedures
4
2014
54
0.640
 Why?
Hyperparathyroidism, Primary
4
2018
35
0.620
 Why?
Hyperparathyroidism
2
2015
30
0.560
 Why?
Iodine Radioisotopes
3
2015
34
0.530
 Why?
Megestrol Acetate
2
2007
17
0.500
 Why?
Parathyroid Diseases
2
2016
5
0.490
 Why?
Bone Density Conservation Agents
2
2007
75
0.480
 Why?
Nursing Homes
2
2007
110
0.480
 Why?
Incidental Findings
3
2013
43
0.450
 Why?
Proton Pump Inhibitors
1
2015
95
0.440
 Why?
Diphosphonates
1
2015
92
0.440
 Why?
Academic Medical Centers
2
2012
153
0.430
 Why?
Thyroglobulin
2
2013
7
0.420
 Why?
Parathyroid Glands
5
2018
20
0.410
 Why?
Carcinoma, Medullary
2
2010
12
0.400
 Why?
Aged
19
2017
10429
0.400
 Why?
Middle Aged
25
2017
13419
0.390
 Why?
Hypothyroidism
2
2011
58
0.360
 Why?
Male
31
2019
27435
0.360
 Why?
Retrospective Studies
14
2019
6819
0.350
 Why?
Calcitonin
2
2010
30
0.350
 Why?
Postoperative Complications
5
2018
1099
0.340
 Why?
Carcinoma
2
2012
136
0.330
 Why?
Humans
44
2019
53230
0.320
 Why?
Algorithms
1
2013
667
0.320
 Why?
Thyroid Nodule
3
2017
32
0.310
 Why?
Female
29
2019
28782
0.290
 Why?
Weight Loss
2
2009
257
0.290
 Why?
Appetite Stimulants
1
2007
5
0.270
 Why?
Cachexia
1
2007
28
0.260
 Why?
Aged, 80 and over
9
2017
3494
0.260
 Why?
Teriparatide
1
2007
10
0.260
 Why?
Four-Dimensional Computed Tomography
2
2017
26
0.240
 Why?
Calcium
3
2018
373
0.240
 Why?
Hypocalcemia
2
2016
13
0.240
 Why?
Pituitary Hormones, Anterior
1
2005
4
0.240
 Why?
Phenylurea Compounds
2
2015
18
0.230
 Why?
Hormones
1
2005
58
0.230
 Why?
Osteoporosis
1
2007
159
0.230
 Why?
Quinolines
2
2015
44
0.230
 Why?
Transcriptional Activation
1
2005
128
0.230
 Why?
Pituitary Gland
1
2005
87
0.220
 Why?
Receptors, Estrogen
1
2005
134
0.220
 Why?
Interleukin-6
1
2005
272
0.210
 Why?
NF-kappa B
1
2005
327
0.200
 Why?
Biopsy, Fine-Needle
5
2011
104
0.200
 Why?
Protein Kinase Inhibitors
2
2015
233
0.200
 Why?
Illinois
2
2013
11
0.190
 Why?
Treatment Outcome
8
2015
5595
0.190
 Why?
Adult
13
2017
14534
0.170
 Why?
Gene Expression Regulation
1
2005
1003
0.170
 Why?
Aging
1
2005
714
0.160
 Why?
Young Adult
7
2015
4511
0.160
 Why?
Follow-Up Studies
3
2013
2318
0.150
 Why?
Hyperparathyroidism, Secondary
1
2019
4
0.150
 Why?
Postoperative Period
3
2015
169
0.150
 Why?
Preoperative Care
2
2018
173
0.140
 Why?
Vitamins
2
2018
64
0.140
 Why?
Patient Discharge
3
2016
325
0.140
 Why?
Intraoperative Complications
1
2019
114
0.130
 Why?
Insulin Resistance
2
2009
282
0.130
 Why?
Prospective Studies
2
2013
2411
0.130
 Why?
Antineoplastic Agents
2
2015
1232
0.130
 Why?
United States
5
2015
5409
0.130
 Why?
Predictive Value of Tests
3
2015
934
0.120
 Why?
Reoperation
1
2018
476
0.120
 Why?
Incidence
2
2011
1085
0.120
 Why?
Hypoparathyroidism
1
2015
5
0.120
 Why?
Carcinoma, Neuroendocrine
1
2015
27
0.110
 Why?
Adolescent
5
2015
6907
0.110
 Why?
Creatinine
1
2015
158
0.110
 Why?
Lymph Nodes
1
2017
252
0.110
 Why?
Costs and Cost Analysis
2
2014
93
0.110
 Why?
Tomography, Emission-Computed, Single-Photon
1
2015
53
0.110
 Why?
Disease Progression
3
2015
880
0.110
 Why?
Diagnosis, Differential
6
2018
1038
0.110
 Why?
Molecular Targeted Therapy
1
2015
138
0.110
 Why?
Ambulatory Care
1
2016
239
0.110
 Why?
Neoplasm Metastasis
2
2015
237
0.100
 Why?
Hospitals, University
1
2014
75
0.100
 Why?
Child, Preschool
2
2013
4162
0.100
 Why?
Sensitivity and Specificity
2
2013
867
0.100
 Why?
Liver
2
2009
1150
0.100
 Why?
Exercise
2
2009
561
0.100
 Why?
Drug Administration Schedule
1
2013
370
0.100
 Why?
Hospitals, Teaching
1
2013
52
0.100
 Why?
Technetium
1
2012
8
0.100
 Why?
Preoperative Period
1
2012
47
0.090
 Why?
Administration, Oral
1
2013
456
0.090
 Why?
Radionuclide Imaging
1
2012
107
0.090
 Why?
Clinical Competence
2
2018
406
0.090
 Why?
Patient Compliance
1
2013
232
0.090
 Why?
Outpatients
1
2013
131
0.090
 Why?
Hospital Charges
1
2012
47
0.090
 Why?
Tumor Burden
1
2012
132
0.090
 Why?
Struma Ovarii
1
2012
5
0.090
 Why?
Cost Savings
1
2012
60
0.090
 Why?
Prognosis
3
2015
2118
0.090
 Why?
Ovariectomy
1
2012
114
0.090
 Why?
Child
3
2013
7379
0.090
 Why?
Immunohistochemistry
2
2012
975
0.090
 Why?
Chromogranin A
1
2010
5
0.080
 Why?
Obesity
2
2009
1204
0.080
 Why?
Dose-Response Relationship, Drug
1
2013
1367
0.080
 Why?
Radiation Monitoring
1
2010
7
0.080
 Why?
Inpatients
1
2011
208
0.080
 Why?
Radiosurgery
1
2011
133
0.080
 Why?
Checklist
1
2010
40
0.080
 Why?
Fatal Outcome
1
2010
193
0.080
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
 Why?
Databases, Factual
1
2013
742
0.080
 Why?
Caloric Restriction
1
2009
39
0.080
 Why?
Ultrasonography
4
2015
426
0.080
 Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.070
 Why?
Intra-Abdominal Fat
1
2009
21
0.070
 Why?
General Surgery
1
2010
108
0.070
 Why?
Occupational Exposure
1
2010
106
0.070
 Why?
Blastomycosis
1
2008
33
0.070
 Why?
Receptors, Thyrotropin
1
2007
6
0.070
 Why?
Symporters
1
2007
15
0.070
 Why?
Ovarian Neoplasms
1
2012
459
0.070
 Why?
Adenoma, Oxyphilic
1
2007
11
0.070
 Why?
Time Factors
3
2015
2991
0.070
 Why?
Whole Body Imaging
1
2007
25
0.070
 Why?
Anorexia
1
2007
7
0.070
 Why?
Severity of Illness Index
1
2011
1049
0.070
 Why?
Adiposity
1
2009
147
0.070
 Why?
DNA, Neoplasm
1
2007
146
0.060
 Why?
Promoter Regions, Genetic
2
2007
465
0.060
 Why?
Calcifediol
1
2006
8
0.060
 Why?
Practice Management, Medical
1
2006
9
0.060
 Why?
Calcium Carbonate
1
2006
11
0.060
 Why?
Medical Audit
1
2006
20
0.060
 Why?
Drug Utilization Review
1
2006
22
0.060
 Why?
Geriatrics
1
2006
42
0.060
 Why?
Drug Monitoring
1
2006
81
0.060
 Why?
Gene Expression Regulation, Neoplastic
1
2010
868
0.060
 Why?
Head
1
2006
72
0.060
 Why?
Cross-Sectional Studies
2
2014
1723
0.060
 Why?
Otolaryngology
1
2006
62
0.060
 Why?
Body Mass Index
2
2009
717
0.060
 Why?
Neck
1
2006
97
0.060
 Why?
Proportional Hazards Models
1
2007
445
0.060
 Why?
Progesterone Congeners
1
2005
5
0.060
 Why?
Body Fat Distribution
1
2005
10
0.060
 Why?
Freezing
1
2005
15
0.060
 Why?
Faculty, Medical
1
2006
92
0.060
 Why?
Arkansas
2
2014
2068
0.060
 Why?
Fractures, Bone
1
2006
106
0.060
 Why?
Serum
1
2005
32
0.060
 Why?
Survival Analysis
1
2007
659
0.060
 Why?
DNA Primers
1
2005
202
0.060
 Why?
Internship and Residency
1
2010
439
0.060
 Why?
Reproducibility of Results
3
2017
1219
0.060
 Why?
HeLa Cells
1
2005
243
0.060
 Why?
Base Sequence
1
2005
620
0.050
 Why?
Nuclear Proteins
1
2005
250
0.050
 Why?
Protein Binding
1
2005
670
0.050
 Why?
Infant
1
2012
3805
0.050
 Why?
ROC Curve
2
2015
246
0.050
 Why?
Patient Selection
2
2018
273
0.050
 Why?
Intraoperative Period
2
2015
46
0.050
 Why?
Randomized Controlled Trials as Topic
1
2005
630
0.050
 Why?
Tomography, X-Ray Computed
3
2012
1180
0.040
 Why?
Thalidomide
1
2002
378
0.040
 Why?
Glucagon
2
2009
24
0.040
 Why?
Cohort Studies
2
2015
1557
0.040
 Why?
Monitoring, Intraoperative
1
2019
51
0.040
 Why?
Cholecalciferol
1
2018
22
0.040
 Why?
Hospitals, High-Volume
1
2018
26
0.040
 Why?
Medical History Taking
1
2018
47
0.040
 Why?
Risk Factors
1
2006
4017
0.030
 Why?
Pilot Projects
2
2010
726
0.030
 Why?
Methylene Blue
1
2017
7
0.030
 Why?
Lymphatic System
1
2017
13
0.030
 Why?
Societies, Medical
1
2018
207
0.030
 Why?
Animals, Genetically Modified
1
2017
54
0.030
 Why?
Coloring Agents
1
2017
65
0.030
 Why?
Mice, Inbred Strains
1
2017
163
0.030
 Why?
Proto-Oncogene Proteins B-raf
1
2017
78
0.030
 Why?
Insulin
2
2009
493
0.030
 Why?
Recurrence
1
2018
694
0.030
 Why?
Lymphatic Metastasis
1
2017
211
0.030
 Why?
Bone Density
1
2018
397
0.030
 Why?
Technetium Tc 99m Sestamibi
1
2015
18
0.030
 Why?
Retreatment
1
2015
60
0.030
 Why?
Brachial Plexus
1
2015
11
0.030
 Why?
Endocrinology
1
2015
11
0.030
 Why?
Axilla
1
2015
92
0.030
 Why?
Hematoma
1
2015
67
0.030
 Why?
Transplantation, Autologous
1
2015
488
0.020
 Why?
Neoplasm Staging
1
2015
774
0.020
 Why?
Hernia, Abdominal
1
2012
5
0.020
 Why?
Activating Transcription Factor 1
1
2012
18
0.020
 Why?
Delayed Diagnosis
1
2012
29
0.020
 Why?
Mutation
1
2017
1337
0.020
 Why?
Ribs
1
2010
16
0.020
 Why?
Thoracotomy
1
2010
33
0.020
 Why?
Neck Dissection
1
2010
30
0.020
 Why?
Mediastinal Neoplasms
1
2010
19
0.020
 Why?
Hypercalcemia
1
2010
34
0.020
 Why?
Feasibility Studies
1
2011
411
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2009
71
0.020
 Why?
Octreotide
1
2009
9
0.020
 Why?
Hospitalization
1
2014
749
0.020
 Why?
Glucose Tolerance Test
1
2009
61
0.020
 Why?
Prevalence
1
2012
1034
0.020
 Why?
Adiponectin
1
2009
47
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
233
0.020
 Why?
Postmenopause
1
2009
85
0.020
 Why?
Absorptiometry, Photon
1
2009
160
0.020
 Why?
Bone Neoplasms
1
2010
188
0.020
 Why?
Eye
1
2008
29
0.020
 Why?
Iodine
1
2007
12
0.020
 Why?
Neoplasm Recurrence, Local
1
2011
647
0.020
 Why?
Body Weight
1
2009
524
0.020
 Why?
Methylation
1
2007
127
0.020
 Why?
Multiple Myeloma
1
2002
3082
0.020
 Why?
Overweight
1
2009
232
0.020
 Why?
Current Procedural Terminology
1
2006
10
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Mice
1
2017
5982
0.020
 Why?
Office Visits
1
2006
45
0.020
 Why?
Polymerase Chain Reaction
1
2007
452
0.020
 Why?
Genetic Predisposition to Disease
1
2009
533
0.020
 Why?
Blood Glucose
1
2009
490
0.010
 Why?
Risk Assessment
1
2010
1368
0.010
 Why?
Lung
1
2008
481
0.010
 Why?
Muscle, Skeletal
1
2009
815
0.010
 Why?
Thyroid Function Tests
1
2002
28
0.010
 Why?
Thyrotropin
1
2002
49
0.010
 Why?
Animals
1
2017
13526
0.010
 Why?
Clinical Trials as Topic
1
2002
466
0.010
 Why?
Bodenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (247) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (31) people
_
Same Department Expand Description
Search Department